These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 8984805

  • 1. [Current concepts of the neuromorphology and neurochemistry of the striatal cholinergic system and its role in regulating movement].
    Shapovalova KB.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1996; 46(4):656-73. PubMed ID: 8984805
    [Abstract] [Full Text] [Related]

  • 2. [The cholinergic system of the striatum: its participation in the motor and sensory components of motor behavior].
    Shapovalova KB.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1997; 47(2):393-411. PubMed ID: 9173743
    [Abstract] [Full Text] [Related]

  • 3. Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease.
    Bonsi P, Cuomo D, Picconi B, Sciamanna G, Tscherter A, Tolu M, Bernardi G, Calabresi P, Pisani A.
    Amino Acids; 2007 Feb; 32(2):189-95. PubMed ID: 16715415
    [Abstract] [Full Text] [Related]

  • 4. Neuronal links in the CNS: focus on dopaminergic and serotonergic regulation of striatal cholinergic neurons.
    Garattini S, Consolo S, Ladinski H.
    Pol J Pharmacol Pharm; 1980 Feb; 32(2):155-64. PubMed ID: 7454621
    [Abstract] [Full Text] [Related]

  • 5. Thalamic regulation of striatal acetylcholine efflux is both direct and indirect and qualitatively altered in the dopamine-depleted striatum.
    Zackheim J, Abercrombie ED.
    Neuroscience; 2005 Feb; 131(2):423-36. PubMed ID: 15708484
    [Abstract] [Full Text] [Related]

  • 6. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA, Rodríguez-Oroz MC, Benitez-Temino B, Blesa FJ, Guridi J, Marin C, Rodriguez M.
    Mov Disord; 2008 Feb; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [Abstract] [Full Text] [Related]

  • 7. Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats.
    Belluscio MA, Riquelme LA, Murer MG.
    Eur J Neurosci; 2007 May; 25(9):2791-804. PubMed ID: 17561844
    [Abstract] [Full Text] [Related]

  • 8. Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems.
    Ariano MA, Grissell AE, Littlejohn FC, Buchanan TM, Elsworth JD, Collier TJ, Steece-Collier K.
    J Neurosci Res; 2005 Nov 01; 82(3):387-96. PubMed ID: 16180225
    [Abstract] [Full Text] [Related]

  • 9. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains.
    Smith Y, Villalba R.
    Mov Disord; 2008 Nov 01; 23 Suppl 3():S534-47. PubMed ID: 18781680
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of effects of systemic (intramuscular) and intrastriatal injections of D1-dopamine receptor blocker on motor behavior and postural adjustment in dogs].
    Shapovalova KB, Kamkina IuV.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2008 Nov 01; 58(5):584-95. PubMed ID: 19004318
    [Abstract] [Full Text] [Related]

  • 11. Dopamine induced switch in the subthreshold dynamics of the striatal cholinergic interneurons: a numerical study.
    Szalisznyó K, Müller L.
    J Theor Biol; 2009 Feb 21; 256(4):547-60. PubMed ID: 18976672
    [Abstract] [Full Text] [Related]

  • 12. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
    Sajadi A, Bauer M, Thöny B, Aebischer P.
    J Neurochem; 2005 Jun 21; 93(6):1482-6. PubMed ID: 15935064
    [Abstract] [Full Text] [Related]

  • 13. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
    Lavoute C, Weiss M, Rostain JC.
    Brain Res; 2007 Oct 24; 1176():37-44. PubMed ID: 17900538
    [Abstract] [Full Text] [Related]

  • 14. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E, Antkiewicz-Michaluk L, Kamińska A, Lenda T, Zieba B, Wierońska J, Smiałowska M, Schulze G, Rommelspacher H.
    Neuroscience; 2008 Oct 28; 156(4):973-86. PubMed ID: 18809471
    [Abstract] [Full Text] [Related]

  • 15. [A possible mechanism of participation of dopaminergic cells and striatal cholinergic interneurons in the conditioned selection of motor activity].
    Sil'kis IG.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2004 Oct 28; 54(6):734-49. PubMed ID: 15658038
    [Abstract] [Full Text] [Related]

  • 16. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
    Ogura T, Ogata M, Akita H, Jitsuki S, Akiba L, Noda K, Hoka S, Saji M.
    Neurosci Res; 2005 Mar 28; 51(3):299-308. PubMed ID: 15710494
    [Abstract] [Full Text] [Related]

  • 17. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
    St-Hilaire M, Landry E, Lévesque D, Rouillard C.
    Neurobiol Dis; 2005 Nov 28; 20(2):450-60. PubMed ID: 15896973
    [Abstract] [Full Text] [Related]

  • 18. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
    Holmer HK, Keyghobadi M, Moore C, Menashe RA, Meshul CK.
    Synapse; 2005 Aug 28; 57(2):100-12. PubMed ID: 15906381
    [Abstract] [Full Text] [Related]

  • 19. Nigrostriatal system plasticity in Parkinson's disease: effect of dopaminergic denervation and treatment.
    Hirsch EC.
    Ann Neurol; 2000 Apr 28; 47(4 Suppl 1):S115-20; discussion S120-1. PubMed ID: 10762138
    [Abstract] [Full Text] [Related]

  • 20. Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats.
    Carta M, Stancampiano R, Tronci E, Collu M, Usiello A, Morelli M, Fadda F.
    Neuroscience; 2006 Apr 28; 139(4):1163-72. PubMed ID: 16530976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.